PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28721338-7	2017	The beneficial action of EPA and DHA reported in the animal experimental models of AAA induced by Ang-II infusion can be attributed to their (EPA and DHA) ability to enhance the formation of not only resolvins, protectins and maresins but also LXA4.	Eicosapentaenoic Acid	25-28	angiotensinogen	Homo sapiens	98-104	
28721338-7	2017	The beneficial action of EPA and DHA reported in the animal experimental models of AAA induced by Ang-II infusion can be attributed to their (EPA and DHA) ability to enhance the formation of not only resolvins, protectins and maresins but also LXA4.	Eicosapentaenoic Acid	142-145	angiotensinogen	Homo sapiens	98-104	
12944026-8	2003	Eicosapentaenoic acid (10 or 25 micromol/L) did not alter basal intracellular calcium concentration, but decreased the peak response to 100 nmol/L angiotensin II.	Eicosapentaenoic Acid	0-21	angiotensinogen	Homo sapiens	147-161	
22475809-3	2012	Here, we determined differential effects of eicosapentaenoic acid (EPA, n-3 PUFA) vs. arachidonic acid (AA, n-6 PUFA) on expression and secretion of angiotensinogen (Agt), interleukin 6 (IL-6) and monocyte chemotactic protein (MCP-1) in 3T3-L1 adipocytes.	Eicosapentaenoic Acid	44-65	angiotensinogen	Homo sapiens	149-164	
22475809-3	2012	Here, we determined differential effects of eicosapentaenoic acid (EPA, n-3 PUFA) vs. arachidonic acid (AA, n-6 PUFA) on expression and secretion of angiotensinogen (Agt), interleukin 6 (IL-6) and monocyte chemotactic protein (MCP-1) in 3T3-L1 adipocytes.	Eicosapentaenoic Acid	67-70	angiotensinogen	Homo sapiens	149-164	
22475809-4	2012	While both PUFAs increased intracellular Agt protein and mRNA expression, Agt secretion into culture media was increased only by AA treatment, which in turn was prevented by co-treatment with EPA.	Eicosapentaenoic Acid	192-195	angiotensinogen	Homo sapiens	74-77	
22475809-6	2012	Moreover, IL-6 and MCP-1 were more significantly reduced by EPA treatment compared to Agt (IL-6>MCP>Agt).	Eicosapentaenoic Acid	60-63	angiotensinogen	Homo sapiens	106-109	
19229829-0	2009	EPA and DHA suppress AngII- and arachidonic acid-induced expression of profibrotic genes in human mesangial cells.	Eicosapentaenoic Acid	0-3	angiotensinogen	Homo sapiens	21-26	
15610248-3	2005	As nitric oxide production via iNOS can inhibit CYP AA metabolism, we tested the hypothesis that by blocking iNOS or by supplementing eicosapentanoic acid (EPA), which can serve as an alternative CYP substrate, Ang II-induced vasculopathy could be ameliorated.	Eicosapentaenoic Acid	134-154	angiotensinogen	Homo sapiens	211-217	
15610248-3	2005	As nitric oxide production via iNOS can inhibit CYP AA metabolism, we tested the hypothesis that by blocking iNOS or by supplementing eicosapentanoic acid (EPA), which can serve as an alternative CYP substrate, Ang II-induced vasculopathy could be ameliorated.	Eicosapentaenoic Acid	156-159	angiotensinogen	Homo sapiens	211-217	
12944026-9	2003	Eicosapentaenoic acid also decreased the amount of calcium released by thapsigargin, a drug that releases calcium from the sarcoplasmic reticulum, and decreased cation influx after angiotensin II stimulation.	Eicosapentaenoic Acid	0-21	angiotensinogen	Homo sapiens	181-195